Correlation Between Aldeyra and C4 Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aldeyra and C4 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aldeyra and C4 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aldeyra and C4 Therapeutics, you can compare the effects of market volatilities on Aldeyra and C4 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aldeyra with a short position of C4 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aldeyra and C4 Therapeutics.

Diversification Opportunities for Aldeyra and C4 Therapeutics

0.73
  Correlation Coefficient

Poor diversification

The 3 months correlation between Aldeyra and CCCC is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Aldeyra and C4 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on C4 Therapeutics and Aldeyra is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aldeyra are associated (or correlated) with C4 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of C4 Therapeutics has no effect on the direction of Aldeyra i.e., Aldeyra and C4 Therapeutics go up and down completely randomly.

Pair Corralation between Aldeyra and C4 Therapeutics

Given the investment horizon of 90 days Aldeyra is expected to generate 3.0 times less return on investment than C4 Therapeutics. But when comparing it to its historical volatility, Aldeyra is 1.59 times less risky than C4 Therapeutics. It trades about 0.03 of its potential returns per unit of risk. C4 Therapeutics is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  189.00  in C4 Therapeutics on September 4, 2024 and sell it today you would earn a total of  241.00  from holding C4 Therapeutics or generate 127.51% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Aldeyra  vs.  C4 Therapeutics

 Performance 
       Timeline  
Aldeyra 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aldeyra has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
C4 Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days C4 Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of conflicting performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Aldeyra and C4 Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aldeyra and C4 Therapeutics

The main advantage of trading using opposite Aldeyra and C4 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aldeyra position performs unexpectedly, C4 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in C4 Therapeutics will offset losses from the drop in C4 Therapeutics' long position.
The idea behind Aldeyra and C4 Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Other Complementary Tools

Commodity Directory
Find actively traded commodities issued by global exchanges
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings